Stockdale Capital Partners acquires ‘West Plano Medical Village’

Property adjacent to Platinum Corridor is class A outpatient facility totaling 49,228 square feet

Stockdale Capital Partners (“Stockdale”), a Los Angeles-based, vertically-integrated real estate investment firm, announced it acquired West Plano Medical Village, a class A outpatient facility totaling 49,228 square feet, located in Plano, Texas, a northern suburb of Dallas. The deal closed on April 16, 2025.

West Plano Medical Village, first developed in 2022, is 100% leased, features 9.8 years of weighted average lease term remaining, and is home to eight tenants providing medical services including primary care, cardiology, pathology, imaging, gastrointestinal, pediatrics, dermatology, and pulmonology. These tenants include Catalyst Physicians Group, Baylor Scott & White, and Catalyst Physicians Group’s affiliated specialists.

“The Plano area benefits from strong submarket demographics that provide for consistent and growing tailwinds for physician practices. Plano experienced a 21% increase in medical office inventory in the past ten years, with steady demand over the same time period,” said Andrew Saba, Managing Director of Healthcare at Stockdale Capital Partners. “We are excited about the opportunity to deepen our relationships with providers like Catalyst, Baylor Scott & White and other providers at West Plano Medical Village.”

Collin County, home to West Plano Medical Village, is one of the fastest-growing counties in the country. West Plano Medical Village is strategically located adjacent to the Platinum Corridor along the tollways running from I-35 to SH-380. Several major corporate relocations in the area include PGA of America, Keurig Dr. Pepper, Frito-Lay, and T-Mobile. The purchase of West Plano Medical Village is Stockdale Capital Partners’ seventh acquisition in its U.S. Healthcare Real Estate Income Fund, which launched in 2023 and now has a portfolio of 415,000 square feet and over $200 million of gross asset value. Stockdale has an active pipeline of medical outpatient acquisitions on the way and is looking to actively acquire more in 2025 and beyond.